vaccination

Search results: 674 items
Search mode
Search in
  • All fields
Date created
Date published
Locations
Categories
Orientation
Russia Coronavirus Vaccine Production

An employee shows a pack of the Russia's Covid-19 vaccine Convasel at the production laboratory of the St. Petersburg Research Institute of Vaccines and Sera of the Russian Federal Medical and Biological Agency (FMBA), in St. Petersburg, Russia. On March 18, the Russian Health Ministry registered the Convasel vaccine. It was developed by the St. Petersburg Research Institute of Vaccines and Sera. The vaccine is a new generation drug that is aimed at generating cellular immunity. The main mechanisms of the effect of the Convasel vaccine are the production of a specific cellular immune response, a central memory cell phenotype, and the development of an intracellular viral neutralizing response.

#8163151
Russia Coronavirus Vaccine Production

An employee shows a pack of the Russia's Covid-19 vaccine Convasel at the production laboratory of the St. Petersburg Research Institute of Vaccines and Sera of the Russian Federal Medical and Biological Agency (FMBA), in St. Petersburg, Russia. On March 18, the Russian Health Ministry registered the Convasel vaccine. It was developed by the St. Petersburg Research Institute of Vaccines and Sera. The vaccine is a new generation drug that is aimed at generating cellular immunity. The main mechanisms of the effect of the Convasel vaccine are the production of a specific cellular immune response, a central memory cell phenotype, and the development of an intracellular viral neutralizing response.

#8163186
Russia Coronavirus Vaccine Production

An employee shows the Russia's Covid-19 vaccine Convasel at the production laboratory of the St. Petersburg Research Institute of Vaccines and Sera of the Russian Federal Medical and Biological Agency (FMBA), in St. Petersburg, Russia. On March 18, the Russian Health Ministry registered the Convasel vaccine. It was developed by the St. Petersburg Research Institute of Vaccines and Sera. The vaccine is a new generation drug that is aimed at generating cellular immunity. The main mechanisms of the effect of the Convasel vaccine are the production of a specific cellular immune response, a central memory cell phenotype, and the development of an intracellular viral neutralizing response.

#8163113
Russia Coronavirus Vaccine Production

A pack of the Russia's Covid-19 vaccine Convasel is seen at the production laboratory of the St. Petersburg Research Institute of Vaccines and Sera of the Russian Federal Medical and Biological Agency (FMBA), in St. Petersburg, Russia. On March 18, the Russian Health Ministry registered the Convasel vaccine. It was developed by the St. Petersburg Research Institute of Vaccines and Sera. The vaccine is a new generation drug that is aimed at generating cellular immunity. The main mechanisms of the effect of the Convasel vaccine are the production of a specific cellular immune response, a central memory cell phenotype, and the development of an intracellular viral neutralizing response.

#8163181
Russia Coronavirus Vaccine Production

An employee works at a Russia's Covid-19 vaccine Convasel production laboratory of the St. Petersburg Research Institute of Vaccines and Sera of the Russian Federal Medical and Biological Agency (FMBA), in St. Petersburg, Russia. On March 18, the Russian Health Ministry registered the Convasel vaccine. It was developed by the St. Petersburg Research Institute of Vaccines and Sera. The vaccine is a new generation drug that is aimed at generating cellular immunity. The main mechanisms of the effect of the Convasel vaccine are the production of a specific cellular immune response, a central memory cell phenotype, and the development of an intracellular viral neutralizing response.

#8163178
Russia Coronavirus Vaccine Production

An employee works at a Russia's Covid-19 vaccine Convasel production laboratory of the St. Petersburg Research Institute of Vaccines and Sera of the Russian Federal Medical and Biological Agency (FMBA), in St. Petersburg, Russia. On March 18, the Russian Health Ministry registered the Convasel vaccine. It was developed by the St. Petersburg Research Institute of Vaccines and Sera. The vaccine is a new generation drug that is aimed at generating cellular immunity. The main mechanisms of the effect of the Convasel vaccine are the production of a specific cellular immune response, a central memory cell phenotype, and the development of an intracellular viral neutralizing response.

#8163149
Russia Coronavirus Vaccine Production

An employee works at a Russia's Covid-19 vaccine Convasel production laboratory of the St. Petersburg Research Institute of Vaccines and Sera of the Russian Federal Medical and Biological Agency (FMBA), in St. Petersburg, Russia. On March 18, the Russian Health Ministry registered the Convasel vaccine. It was developed by the St. Petersburg Research Institute of Vaccines and Sera. The vaccine is a new generation drug that is aimed at generating cellular immunity. The main mechanisms of the effect of the Convasel vaccine are the production of a specific cellular immune response, a central memory cell phenotype, and the development of an intracellular viral neutralizing response.

#8163177
Russia Coronavirus Vaccine Production

An employee works at a Russia's Covid-19 vaccine Convasel production laboratory of the St. Petersburg Research Institute of Vaccines and Sera of the Russian Federal Medical and Biological Agency (FMBA), in St. Petersburg, Russia. On March 18, the Russian Health Ministry registered the Convasel vaccine. It was developed by the St. Petersburg Research Institute of Vaccines and Sera. The vaccine is a new generation drug that is aimed at generating cellular immunity. The main mechanisms of the effect of the Convasel vaccine are the production of a specific cellular immune response, a central memory cell phenotype, and the development of an intracellular viral neutralizing response.

#8163145
Russia Coronavirus Vaccine Production

An employee works at a Russia's Covid-19 vaccine Convasel production laboratory of the St. Petersburg Research Institute of Vaccines and Sera of the Russian Federal Medical and Biological Agency (FMBA), in St. Petersburg, Russia. On March 18, the Russian Health Ministry registered the Convasel vaccine. It was developed by the St. Petersburg Research Institute of Vaccines and Sera. The vaccine is a new generation drug that is aimed at generating cellular immunity. The main mechanisms of the effect of the Convasel vaccine are the production of a specific cellular immune response, a central memory cell phenotype, and the development of an intracellular viral neutralizing response.

#8163176
Russia Coronavirus Vaccine Production

An employee works at a Russia's Covid-19 vaccine Convasel production laboratory of the St. Petersburg Research Institute of Vaccines and Sera of the Russian Federal Medical and Biological Agency (FMBA), in St. Petersburg, Russia. On March 18, the Russian Health Ministry registered the Convasel vaccine. It was developed by the St. Petersburg Research Institute of Vaccines and Sera. The vaccine is a new generation drug that is aimed at generating cellular immunity. The main mechanisms of the effect of the Convasel vaccine are the production of a specific cellular immune response, a central memory cell phenotype, and the development of an intracellular viral neutralizing response.

#8163135
Russia Coronavirus Vaccine Production

An employee shows a pack of the Russia's Covid-19 vaccine Convasel at the production laboratory of the St. Petersburg Research Institute of Vaccines and Sera of the Russian Federal Medical and Biological Agency (FMBA), in St. Petersburg, Russia. On March 18, the Russian Health Ministry registered the Convasel vaccine. It was developed by the St. Petersburg Research Institute of Vaccines and Sera. The vaccine is a new generation drug that is aimed at generating cellular immunity. The main mechanisms of the effect of the Convasel vaccine are the production of a specific cellular immune response, a central memory cell phenotype, and the development of an intracellular viral neutralizing response.

#8163173
Russia Coronavirus Vaccine Production

An employee works at a Russia's Covid-19 vaccine Convasel production laboratory of the St. Petersburg Research Institute of Vaccines and Sera of the Russian Federal Medical and Biological Agency (FMBA), in St. Petersburg, Russia. On March 18, the Russian Health Ministry registered the Convasel vaccine. It was developed by the St. Petersburg Research Institute of Vaccines and Sera. The vaccine is a new generation drug that is aimed at generating cellular immunity. The main mechanisms of the effect of the Convasel vaccine are the production of a specific cellular immune response, a central memory cell phenotype, and the development of an intracellular viral neutralizing response.

#8163128
Russia Coronavirus Vaccine Production

An employee works at a Russia's Covid-19 vaccine Convasel production laboratory of the St. Petersburg Research Institute of Vaccines and Sera of the Russian Federal Medical and Biological Agency (FMBA), in St. Petersburg, Russia. On March 18, the Russian Health Ministry registered the Convasel vaccine. It was developed by the St. Petersburg Research Institute of Vaccines and Sera. The vaccine is a new generation drug that is aimed at generating cellular immunity. The main mechanisms of the effect of the Convasel vaccine are the production of a specific cellular immune response, a central memory cell phenotype, and the development of an intracellular viral neutralizing response.

#8163125
Russia Coronavirus Vaccine Production

An employee works at a Russia's Covid-19 vaccine Convasel production laboratory of the St. Petersburg Research Institute of Vaccines and Sera of the Russian Federal Medical and Biological Agency (FMBA), in St. Petersburg, Russia. On March 18, the Russian Health Ministry registered the Convasel vaccine. It was developed by the St. Petersburg Research Institute of Vaccines and Sera. The vaccine is a new generation drug that is aimed at generating cellular immunity. The main mechanisms of the effect of the Convasel vaccine are the production of a specific cellular immune response, a central memory cell phenotype, and the development of an intracellular viral neutralizing response.

#8163124
Russia Coronavirus Vaccine Production

An employee works at a Russia's Covid-19 vaccine Convasel production laboratory of the St. Petersburg Research Institute of Vaccines and Sera of the Russian Federal Medical and Biological Agency (FMBA), in St. Petersburg, Russia. On March 18, the Russian Health Ministry registered the Convasel vaccine. It was developed by the St. Petersburg Research Institute of Vaccines and Sera. The vaccine is a new generation drug that is aimed at generating cellular immunity. The main mechanisms of the effect of the Convasel vaccine are the production of a specific cellular immune response, a central memory cell phenotype, and the development of an intracellular viral neutralizing response.

#8163172
Russia Coronavirus Vaccine Production

An employee works at a Russia's Covid-19 vaccine Convasel production laboratory of the St. Petersburg Research Institute of Vaccines and Sera of the Russian Federal Medical and Biological Agency (FMBA), in St. Petersburg, Russia. On March 18, the Russian Health Ministry registered the Convasel vaccine. It was developed by the St. Petersburg Research Institute of Vaccines and Sera. The vaccine is a new generation drug that is aimed at generating cellular immunity. The main mechanisms of the effect of the Convasel vaccine are the production of a specific cellular immune response, a central memory cell phenotype, and the development of an intracellular viral neutralizing response.

#8163159
Russia Coronavirus Vaccine Production

An employee works at a Russia's Covid-19 vaccine Convasel production laboratory of the St. Petersburg Research Institute of Vaccines and Sera of the Russian Federal Medical and Biological Agency (FMBA), in St. Petersburg, Russia. On March 18, the Russian Health Ministry registered the Convasel vaccine. It was developed by the St. Petersburg Research Institute of Vaccines and Sera. The vaccine is a new generation drug that is aimed at generating cellular immunity. The main mechanisms of the effect of the Convasel vaccine are the production of a specific cellular immune response, a central memory cell phenotype, and the development of an intracellular viral neutralizing response.

#8163120
Russia Coronavirus Vaccine Production

An employee works at a Russia's Covid-19 vaccine Convasel production laboratory of the St. Petersburg Research Institute of Vaccines and Sera of the Russian Federal Medical and Biological Agency (FMBA), in St. Petersburg, Russia. On March 18, the Russian Health Ministry registered the Convasel vaccine. It was developed by the St. Petersburg Research Institute of Vaccines and Sera. The vaccine is a new generation drug that is aimed at generating cellular immunity. The main mechanisms of the effect of the Convasel vaccine are the production of a specific cellular immune response, a central memory cell phenotype, and the development of an intracellular viral neutralizing response.

#8163158
Russia Coronavirus Vaccine Production

An employee works at a Russia's Covid-19 vaccine Convasel production laboratory of the St. Petersburg Research Institute of Vaccines and Sera of the Russian Federal Medical and Biological Agency (FMBA), in St. Petersburg, Russia. On March 18, the Russian Health Ministry registered the Convasel vaccine. It was developed by the St. Petersburg Research Institute of Vaccines and Sera. The vaccine is a new generation drug that is aimed at generating cellular immunity. The main mechanisms of the effect of the Convasel vaccine are the production of a specific cellular immune response, a central memory cell phenotype, and the development of an intracellular viral neutralizing response.

#8163157
Russia Coronavirus Vaccine Production

An employee works at a Russia's Covid-19 vaccine Convasel production laboratory of the St. Petersburg Research Institute of Vaccines and Sera of the Russian Federal Medical and Biological Agency (FMBA), in St. Petersburg, Russia. On March 18, the Russian Health Ministry registered the Convasel vaccine. It was developed by the St. Petersburg Research Institute of Vaccines and Sera. The vaccine is a new generation drug that is aimed at generating cellular immunity. The main mechanisms of the effect of the Convasel vaccine are the production of a specific cellular immune response, a central memory cell phenotype, and the development of an intracellular viral neutralizing response.

#8163156